CXCR4 in Waldenström's Macroglobulinemia: chances and challenges

Buske C, et al.

Leukemia · 2021

Grade Bnarrative review

Key Findings

  • CXCR4 mutations affect up to 40% of WM patients with >40 different mutations described
  • Mutations similar to germline WHIM syndrome mutations
  • CXCR4 mutations lead to more aggressive clinical course and inferior BTK inhibitor response

Referenced in (1 disease)

ID: pmid-33273682DOI: 10.1038/s41375-020-01102-3PMID: 33273682